Home Diseases and Conditions Gestational Trophoblastic Disease

Gestational Trophoblastic Disease

Last Updated:
Development Stage

Early Stage

Focused ultrasound research is in the laboratory phase and is not yet available for patients.

Clinical Trials

Focused ultrasound for this condition is being researched in clinical trials.

International Approval

Focused ultrasound is approved to treat this condition outside the US. Patients can seek commercial treatment at participating international sites.

FDA Approved

The US Food and Drug Administration has approved focus ultrasound for this condition. Patients can seek commercial treatment at participating sites.

Early Stage

Clinical Trials

International

FDA Approved

Focused ultrasound for this condition has been researched in clinical trials. However, at this time, we are not aware of any open clinical trials.

Focused Ultrasound Therapy

Focused ultrasound is a therapeutic technology that could improve the quality of life and decrease the cost of care for patients with gestational trophoblastic disease. This novel technology focuses beams of ultrasound energy precisely and accurately on targets deep in the body without damaging surrounding normal tissue.

How it Works
Where the beams converge, focused ultrasound produces therapeutic thermal ablation, which destroys the target tissue.

The primary options for treatment of gestational trophoblastic disease include invasive surgery with probable loss of the potential for future pregnancies.

For certain patients, focused ultrasound could provide a non-invasive alternative to surgery with less risk of complications and lower cost.

Advantages

  • Focused ultrasound is noninvasive, so it does not carry added concerns like surgical wound healing or infection.
  • Focused ultrasound can reach the desired target without damaging surrounding tissue.
  • It can be repeated, if necessary.

Clinical Trials

At the present time, there are no clinical trials recruiting patients for focused ultrasound treatment of gestational trophoblastic disease.

Regulatory Approval and Reimbursement

Focused ultrasound treatment for gestational trophoblastic disease is not yet approved by regulatory bodies or covered by medical insurance companies.

Notable Papers

Qu D, Chen Y, Jiang J, Shi Q, Zhou H, Wang Z. Long-term outcome of ultrasound-guided focused ultrasound ablation for gestational trophoblastic neoplasia in the cesarean scar: a case report. BMC Womens Health. 2022 Dec 15;22(1):522. doi: 10.1186/s12905-022-02114-0. PMID: 36522625

Click here for additional references from PubMed.